Array Biopharma Inc Watch

from 8-K 34 pages Array Biopharma Inc. 20,930,232 Shares of Common Stock Underwriting Agreement

from 8-K 33 pages Array Biopharma Inc. 18,400,000 Shares of Common Stock Underwriting Agreement

from S-3ASR 4 pages Array Biopharma Inc. Controlled Equity Offeringsm Amendment No. 2 to Sales Agreement

from POS AM 5 pages Array Biopharma Inc. Controlled Equity Offeringsm Amendment No. 1 to Sales Agreement

from 8-K 31 pages Array Biopharma Inc. 3.00% Convertible Senior Notes Due 2020 Underwriting Agreement

from 8-K 49 pages 18,000,000 Shares Array Biopharma Inc. Underwriting Agreement

from 8-K 49 pages 20,000,000 Shares Array Biopharma Inc. Underwriting Agreement

from 8-K 6 pages Fifth Amendment to Loan and Security Agreement

from 8-K 37 pages $25,000,000 Array Biopharma Inc. Common Stock Equity Distribution Agreement

from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934

from SC 13G 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934

from 8-K 40 pages Array Biopharma Inc. 7,000,000 Shares of Common Stock ($0.001 Par Value Per Share) Underwriting Agreement

from 8-K 46 pages Array Biopharma Inc. 8,000,000 Shares Common Stock ($0.001 Par Value Per Share) Underwriting Agreement

from SC 13G 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 10, 2003, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $.001 Per Share, of Array Biopharma Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 10th Day of November, 2003. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Orbimed Capital LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly <page>

from SC 13G 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g, Dated November 10, 2003, (The "Schedule 13g"), With Respect to the Common Stock, Par Value $.001 Per Share, of Array Biopharma Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 10th Day of November, 2003. Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member Orbimed Capital LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: Managing Member By: /S/ Samuel D. Isaly Name: Samuel D. Isaly <page>

from SC 13G ~1 page Agreement Regarding Joint Filing

from S-3/A ~50 pages Ex-1.1 Form of Underwriting Agreement

from SC 13G 1 page <page> 1 <table> <s> <c> - Cusip No. 04269x10 13g Page 11 of 11 Pages - Exhibit 1 Agreement Pursuant to Rule 13d-1(k)(1) Under the Securities Exchange Act of 1934, the Undersigned Hereby Agree That Only One Statement Containing the Information Required by Schedule 13g Need Be Filed With Respect to the Ownership by Each of the Undersigned of Shares of Common Stock of Array Biopharma Inc. This Agreement May Be Executed in Any Number of Counterparts, Each of Which Shall Be Deemed an Original. Executed This 7th Day of February, 2001. Frazier Healthcare II, L.P. By: Fhm II, L.L.C. Its General Partner By: Frazier Management, L.L.C. Its Managing Member By: Frazier & Company, Inc. Its Managing Member By: /S/ Alan D. Frazier Alan D. Frazier, President Fhm II. L.L.C. By: Frazier Management, L.L.C. Its Managing Member By: Frazier & Company, Inc. Its Managing Member By: /S/ Alan D. Frazier Alan D. Frazier, President Frazier Management, L.L.C. By: Frazier & Company, Inc. Its Managing Member By: /S/ Alan D. Frazier Alan D. Frazier, President Frazier & Company, Inc. By: /S/ Alan D. Frazier Alan D. Frazier, President, Director and Shareholder /S/ Alan D. Frazier Alan D. Frazier </Table> Page 11 of 11 Pages

from POS EX ~20 pages Underwriting Agreement

from S-1/A ~50 pages Underwriting Agreement